Literature DB >> 12542491

Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma.

Masahiro Kami1, Tamae Hamaki, Shigesaburo Miyakoshi, Naoko Murashige, Yoshinobu Kanda, Ryuji Tanosaki, Yoichi Takaue, Shuichi Taniguchi, Hisamaru Hirai, Keiya Ozawa, Masaharu Kasai.   

Abstract

The feasibility of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) in 11 patients with adult T-cell leukaemia/lymphoma (ATL) (6 acute, 4 lymphoma, 1 chronic type) was evaluated. The preparative regimens (9 conventional, 2 reduced-intensity) were tolerable. Five patients developed acute graft-versus-host disease (GVHD), and three, extensive chronic GVHD. All 10 patients who survived > 30 d achieved complete remission. Estimated 1-year overall and disease-free survival rates were 53 +/- 30% and 45 +/- 29% respectively. Four patients remain alive and disease-free at a median follow-up of 25 months. The others died of transplantation-related complications. This pilot study suggests that allo-HSCT in ATL should be evaluated further.

Entities:  

Mesh:

Year:  2003        PMID: 12542491     DOI: 10.1046/j.1365-2141.2003.04054.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

Review 1.  Adult T cell leukemia lymphoma.

Authors:  Lee Ratner
Journal:  Front Biosci       Date:  2004-09-01

2.  Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experience.

Authors:  Takuya Fukushima; Jun Taguchi; Yukiyoshi Moriuchi; Shinichiro Yoshida; Hidehiro Itonaga; Koji Ando; Yasushi Sawayama; Yoshitaka Imaizumi; Daisuke Imanishi; Tomoko Hata; Yasushi Miyazaki
Journal:  Int J Hematol       Date:  2011-09-30       Impact factor: 2.490

3.  Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.

Authors:  Masakatsu Hishizawa; Kazunori Imada; Tomomi Sakai; Momoko Nishikori; Nobuyoshi Arima; Mitsuru Tsudo; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

4.  Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor.

Authors:  Hiroshi Fujiwara; Hideaki Kawada; Kakushi Matsushita; Heiichiro Hamada; Atsuo Ozaki; Hirosaka Inoue; Makoto Yoshimitsu; Toshimasa Kukita; Kosei Arimura; Hideo Ohtsubo; Kimiharu Uozumi; Naomichi Arima; Chuwa Tei
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

5.  Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network.

Authors:  Takuya Fukushima; Hidehiro Itonaga; Yukiyoshi Moriuchi; Shinichiro Yoshida; Jun Taguchi; Yoshitaka Imaizumi; Daisuke Imanishi; Hideki Tsushima; Yasushi Sawayama; Emi Matsuo; Tomoko Hata; Yasushi Miyazaki
Journal:  Int J Hematol       Date:  2013-03-13       Impact factor: 2.490

6.  Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.

Authors:  A Bazarbachi; K Cwynarski; A Boumendil; H Finel; P Fields; K Raj; A Nagler; M Mohty; A Sureda; P Dreger; O Hermine
Journal:  Bone Marrow Transplant       Date:  2014-07-14       Impact factor: 5.483

7.  Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation.

Authors:  Nanae Harashima; Ryuji Tanosaki; Yukiko Shimizu; Kiyoshi Kurihara; Takao Masuda; Jun Okamura; Mari Kannagi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 8.  Human T cell lymphotropic virus-associated leukemia/lymphoma.

Authors:  Lee Ratner
Journal:  Curr Opin Oncol       Date:  2005-09       Impact factor: 3.645

9.  A case of post-mogamulizumab relapse of acute-type adult T-cell leukemia/lymphoma successfully treated with mogamulizumab and etoposide.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Kunimo Ichikawa; Mutsumi Wakabayashi; Keiji Sugimoto; Ayako Kinoshita; Yasushi Suga; Shigeki Tomita; Hiroshi Izumi; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 10.  Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma.

Authors:  Jun Okamura; Naokuni Uike; Atae Utsunomiya; Ryuji Tanosaki
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.